{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:08:11Z","timestamp":1789056491146,"version":"build-2803163510"},"reference-count":164,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013152","name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["SIMM0120231003"],"award-info":[{"award-number":["SIMM0120231003"]}],"id":[{"id":"10.13039\/501100013152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2025CXPT012"],"award-info":[{"award-number":["2025CXPT012"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Key Research and Development Projects of Shaanxi Province","doi-asserted-by":"publisher","award":["2024CXPT029"],"award-info":[{"award-number":["2024CXPT029"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.virs.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T06:13:14Z","timestamp":1783318394000},"page":"735-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent progress in anti-Chikungunya virus drug discovery: Focus on the viral life cycle and direct-acting antivirals"],"prefix":"10.1016","volume":"41","author":[{"given":"Chunjiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-2571","authenticated-orcid":false,"given":"Leike","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2369-4765","authenticated-orcid":false,"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5941-6105","authenticated-orcid":false,"given":"Xiangrui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.07.001_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00649-20","article-title":"Novel class of chikungunya Virus small molecule inhibitors that targets the viral capping machinery","volume":"64","author":"Abdelnabi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150393","article-title":"Inhibition of early RNA replication in Chikungunya and Dengue virus by lycorine: in vitro and in silico studies","volume":"730","author":"Agrawal","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virs.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1021\/acs.jmedchem.0c02183","article-title":"Targeting Chikungunya virus replication by benzoannulene inhibitors","volume":"64","author":"Ahmed","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s12033-025-01461-1","article-title":"Anti-Chikungunya activity of a cinnamic acid derivative: an in vitro and in silico study","volume":"68","author":"Alagarasu","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.virs.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00232-007-9003-6","article-title":"The alphavirus 6K protein activates endogenous ionic conductances when expressed in xenopus oocytes","volume":"215","author":"Antoine","year":"2007","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.virs.2026.07.001_bib7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1099\/vir.0.82714-0","article-title":"Genetic divergence of Chikungunya viruses in India (1963\u20132006) with special reference to the 2005\u20132006 explosive epidemic","volume":"88","author":"Arankalle","year":"2007","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib8","article-title":"Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening","author":"Aschenbrenner","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.virs.2026.07.001_bib9","article-title":"Chikungunya virus release is reduced by TIM-1 receptors through binding of envelope phosphatidylserine","volume":"98","author":"Ballista","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib10","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (Favipiravir) induces lethal mutagenesis in Influenza a H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib11","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/acsinfecdis.0c00915","article-title":"Discovery of a Potent and Selective Chikungunya virus envelope protein inhibitor through computer-aided drug design","volume":"7","author":"Battini","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116010","article-title":"Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus","volume":"264","author":"Battisti","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110111","article-title":"Viral methyltransferase inhibitors: berbamine, venetoclax, and ponatinib as efficacious antivirals against Chikungunya virus","volume":"759","author":"Bhutkar","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.virs.2026.07.001_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s00284-024-03874-8","article-title":"New highly selective antivirals for Chikungunya virus identified from the screening of a drug-like compound library","volume":"81","author":"Castro","year":"2024","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.virs.2026.07.001_bib15","article-title":"A review on Chikungunya virus epidemiology, pathogenesis and current vaccine development","volume":"14","author":"Cavalcanti","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.07.001_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.antiviral.2017.04.001","article-title":"Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities","volume":"143","author":"Chen","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"9811","DOI":"10.1021\/acs.jmedchem.5c00626","article-title":"Design and development of a novel oral 4'-Fluorouridine double prodrug VV261 against SFTSV","volume":"68","author":"Cheng","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib18","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1021\/acs.jmedchem.5b01047","article-title":"Trisubstituted thieno[3,2-b]pyrrole 5-carboxamides as potent inhibitors of alphaviruses","volume":"58","author":"Ching","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib19","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1021\/acs.jmedchem.7b00180","article-title":"Structural optimizations of thieno[3,2-b]pyrrole derivatives for the development of metabolically stable inhibitors of Chikungunya virus","volume":"60","author":"Ching","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib20","article-title":"A meta-analysis of Chikungunya virus in neurological disorders","volume":"54","author":"Costa","year":"2024","journal-title":"Infect. Dis. Now."},{"key":"10.1016\/j.virs.2026.07.001_bib21","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.1073\/pnas.85.21.8052","article-title":"Dissection of Semliki Forest virus glycoprotein delivery from the trans-Golgi network to the cell surface in permeabilized BHK cells","volume":"85","author":"Curtis","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.virs.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1128\/AAC.01421-16","article-title":"Design and validation of novel Chikungunya virus protease inhibitors","volume":"60","author":"Das","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41579-025-01177-8","article-title":"Chikungunya virus and other emerging arthritogenic alphaviruses","volume":"23","author":"de Souza","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.07.001_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2675","article-title":"Conventional and unconventional mechanisms for capping viral mRNA","volume":"10","author":"Decroly","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.07.001_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/srep31819","article-title":"The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection","volume":"6","author":"Delang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the Chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/171344a0","article-title":"A new antifungal substance of fungal origin","volume":"171","author":"Delmotte","year":"1953","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.07.001_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib29","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1016\/j.bmc.2014.09.013","article-title":"Structure\u2013activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication","volume":"22","author":"Di Mola","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02395-16","article-title":"Characterization of \u03b2-d-N4-Hydroxycytidine as a novel inhibitor of Chikungunya virus","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104808","article-title":"Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection","volume":"179","author":"Fatma","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib32","series-title":"FDA Approves First Vaccine to Prevent Disease Caused by Chikungunya Virus","year":"2023"},{"key":"10.1016\/j.virs.2026.07.001_bib33","series-title":"FDA Update on the Safety of Ixchiq (Chikungunya Vaccine, Live)","year":"2025"},{"key":"10.1016\/j.virs.2026.07.001_bib34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/17568919.2025.2504337","article-title":"Benzothiazole derivatives as inhibitors of Chikungunya virus replicative cycle","volume":"17","author":"Feferbaum-Leite","year":"2025","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","article-title":"Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme","volume":"154","author":"Feibelman","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib36","article-title":"Beyond members of the flaviviridae family, sofosbuvir also inhibits Chikungunya virus replication","volume":"63","author":"Ferreira","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14790-x","article-title":"Characterization of the RNA-dependent RNA polymerase from Chikungunya virus and discovery of a novel ligand as a potential drug candidate","volume":"12","author":"Freire","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jap. Acad., Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.virs.2026.07.001_bib39","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.49.3.981-986.2005","article-title":"Mechanism of action of T-705 against Influenza virus","volume":"49","author":"Furuta","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib40","series-title":"Viral Polym","article-title":"RNA-dependent RNA polymerases and their emerging roles in antiviral therapy","author":"Ganeshpurkar","year":"2019"},{"key":"10.1016\/j.virs.2026.07.001_bib41","doi-asserted-by":"crossref","first-page":"20858","DOI":"10.1021\/acs.jmedchem.4c01073","article-title":"4-Substituted-2-thiazole amides as viral replication inhibitors of alphaviruses","volume":"67","author":"Garzan","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108737","article-title":"Identification of sulfonamide drugs as allosteric inhibitor of Chikungunya virus envelope glycoprotein: an in silico approach for drug repurposing","volume":"120","author":"Gaur","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib43","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s13337-019-00547-0","article-title":"In silico study of Chikungunya polymerase, a potential target for inhibitors","volume":"30","author":"Ghildiyal","year":"2019","journal-title":"Virusdisease"},{"key":"10.1016\/j.virs.2026.07.001_bib44","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1021\/acs.jmedchem.4c01346","article-title":"Structure activity of \u03b2-amidomethyl vinyl sulfones as covalent inhibitors of Chikungunya nsP2 cysteine protease with antialphavirus activity","volume":"67","author":"Ghoshal","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib45","doi-asserted-by":"crossref","first-page":"22918","DOI":"10.1021\/acs.jmedchem.5c01802","article-title":"N-alkyl sulfamates as a new class of nsP2 cysteine protease inhibitors with broad-spectrum antialphaviral activity","volume":"68","author":"Ghoshal","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.antiviral.2017.06.003","article-title":"Antiviral activity of [1,2,3]triazolo[4,5- d ]pyrimidin-7(6 H)-ones against Chikungunya virus targeting the viral capping nsP1","volume":"144","author":"Gigante","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib47","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/acsinfecdis.7b00219","article-title":"Inhibition of the replication of different strains of Chikungunya virus by 3-aryl-[1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones","volume":"4","author":"G\u00f3mez-SanJuan","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177322","article-title":"A brief overview of Chikungunya-related pain","volume":"994","author":"Gon\u00e7alves","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.virs.2026.07.001_bib49","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1073\/pnas.82.14.4648","article-title":"Sequence analysis of three Sindbis virus mutants temperature-sensitive in the capsid protein autoprotease","volume":"82","author":"Hahn","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.virs.2026.07.001_bib50","doi-asserted-by":"crossref","DOI":"10.26633\/RPSP.2017.61","article-title":"Chikungunya virus outbreak in Sint Maarten, 2013\u20132014","volume":"41","author":"Henry","year":"2017","journal-title":"Rev. Panam. Salud P\u00fablic"},{"key":"10.1016\/j.virs.2026.07.001_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008876","article-title":"A molecular understanding of alphavirus entry","volume":"16","author":"Holmes","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.07.001_bib52","article-title":"A single mutation in Chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Holmes","year":"2007","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.07.001_bib53","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1021\/acsomega.1c00447","article-title":"Inhibition of Chikungunya virus infection by 4-hydroxy-1-methyl-3-(3-morpholinopropanoyl)quinoline-2(1H)-one (QVIR) targeting nsP2 and E2 proteins","volume":"6","author":"Islamuddin","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.virs.2026.07.001_bib54","doi-asserted-by":"crossref","first-page":"10884","DOI":"10.1021\/acsomega.1c00625","article-title":"Novel analogues of the Chikungunya virus protease inhibitor: molecular design, synthesis, and biological evaluation","volume":"6","author":"Ivanova","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.virs.2026.07.001_bib55","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1021\/acsomega.0c06191","article-title":"1,3-thiazolbenzamide derivatives as Chikungunya virus nsP2 protease inhibitors","volume":"6","author":"Ivanova","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.virs.2026.07.001_bib56","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2014.10.042","article-title":"Thiazolidone derivatives as inhibitors of Cikungunya virus","volume":"89","author":"Jadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib57","first-page":"754","article-title":"Advances in Chikungunya virus inhibitors","volume":"55","author":"Jiang","year":"2020","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.virs.2026.07.001_bib58","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1126\/scitranslmed.3005471","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virs.2026.07.001_bib59","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2213934120","article-title":"Structural basis and dynamics of Chikungunya alphavirus RNA capping by nsP1 capping pores","volume":"120","author":"Jones","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.virs.2026.07.001_bib60","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/fmb.09.59","article-title":"A structural and functional perspective of alphavirus replication and assembly","volume":"4","author":"Joyce","year":"2009","journal-title":"Future Microbiol."},{"key":"10.1016\/j.virs.2026.07.001_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0885715622000495","article-title":"Crystal structure of oxibendazole, C12H15N3O3","volume":"38","author":"Kaduk","year":"2023","journal-title":"Powder Diffr."},{"key":"10.1016\/j.virs.2026.07.001_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022336","article-title":"NTPase and 5\u2032-RNA triphosphatase activities of Chikungunya virus nsP2 protein","volume":"6","author":"Karpe","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.07.001_bib63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/AAC.01467-12","article-title":"Inhibition of Chikungunya virus replication by Harringtonine, a novel antiviral that suppresses viral protein expression","volume":"57","author":"Kaur","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00336-14","article-title":"Complete genome sequence of Chikungunya virus isolated in the Philippines","volume":"2","author":"Kawashima","year":"2014","journal-title":"Genome Announc."},{"key":"10.1016\/j.virs.2026.07.001_bib65","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/v2040796","article-title":"Alphavirus entry and membrane fusion","volume":"2","author":"Kielian","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.07.001_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrmicro1326","article-title":"Virus membrane-fusion proteins: more than one way to make a hairpin","volume":"4","author":"Kielian","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virs.2026.07.001_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02566-20","article-title":"Structural insights into the mechanisms of action of functionally distinct classes of Chikungunya virus nonstructural protein 1 inhibitors","volume":"65","author":"Kovacikova","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02532-19","article-title":"6\u2032-\u03b2-Fluoro-Homoaristeromycin and 6\u2032-Fluoro-Homoneplanocin A are potent inhibitors of Chikungunya virus replication through their direct effect on viral nonstructural protein 1. Antimicrob","volume":"64","author":"Kovacikova","year":"2020","journal-title":"Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib69","article-title":"Crystal structure of Aura virus capsid protease and its complex with dioxane: new insights into capsid-glycoprotein molecular contacts","volume":"7","author":"Krummenacher","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.07.001_bib70","article-title":"Multiple roles of the non-structural protein 3 (nsP3) alphavirus unique domain (AUD) during Chikungunya virus genome replication and transcription","volume":"15","author":"Kuhn","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.07.001_bib71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2021.05.013","article-title":"Identification and evaluation of antiviral potential of thymoquinone, a natural compound targeting Chikungunya virus capsid protein","volume":"561","author":"Kumar","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.07.001_bib72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4103\/apjtm.apjtm_525_25","article-title":"Challenges in diagnosis and control of Chikungunya virus infection: a review","volume":"18","author":"Kumar","year":"2025","journal-title":"Asian Pac. J. Tropical Med."},{"key":"10.1016\/j.virs.2026.07.001_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30193942","article-title":"Ion-channel-targeting drugs for Chikungunya virus","volume":"30","author":"Lahiri","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.virs.2026.07.001_bib74","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1073\/pnas.1900656116","article-title":"Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase","volume":"116","author":"Law","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.virs.2026.07.001_bib75","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2016.07.009","article-title":"Antiviral activity of selected flavonoids against Chikungunya virus","volume":"133","author":"Lani","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib77","first-page":"2378","article-title":"Advances in anti-chikungunya fever drugs","volume":"34","author":"Li","year":"2025","journal-title":"Chin. J. New Drugs"},{"key":"10.1016\/j.virs.2026.07.001_bib78","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature09546","article-title":"Structural changes of envelope proteins during alphavirus fusion","volume":"468","author":"Li","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.07.001_bib76","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jare.2025.11.043","article-title":"Cinnamic acid derivatives in agrochemicals: current use and future perspective","volume":"86","author":"Lei","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib79","article-title":"A quantitative high-throughput screening pipeline to identify small molecule inhibitors of Chikungunya nsP2 protease","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib80","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0035-9203(55)90081-X","article-title":"An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952\u20131953 II. General description and epidemiology","volume":"49","author":"Lumsden","year":"1955","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.virs.2026.07.001_bib81","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1128\/JVI.00189-09","article-title":"The crystal structures of Chikungunya and Venezuelan Equine Encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket","volume":"83","author":"Malet","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib82","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0140-6736(25)00571-9","article-title":"Safety and immunogenicity of a virus-like particle Chikungunya virus vaccine","volume":"405","author":"Marques","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.07.001_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126881","article-title":"Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus inhibitors","volume":"30","author":"Marra","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.virs.2026.07.001_bib85","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01398-21","article-title":"Macrodomain binding compound MRS 2578 inhibits alphavirus replication","volume":"65","author":"Mattila","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib86","doi-asserted-by":"crossref","first-page":"46923","DOI":"10.1074\/jbc.M207847200","article-title":"Alphavirus 6K proteins form ion channels","volume":"277","author":"Melton","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib87","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2409166121","article-title":"Identification of a cell-active Chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach","volume":"121","author":"Merten","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.virs.2026.07.001_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116808","article-title":"Inhibitor of the non-structural protein 2 protease shows promising efficacy in mouse models of Chikungunya","volume":"278","author":"Metibemu","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/srep20122","article-title":"Inhibition of Chikungunya virus replication by 1-[(2-methylbenzimidazol-1-yl)methyl]-2-oxo-indolin-3-ylidene] amino] thiourea (MBZM-N-IBT)","volume":"6","author":"Mishra","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib90","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1021\/acsmedchemlett.9b00662","article-title":"Identification of 2-(4-(phenylsulfonyl)piperazine-1-yl)pyrimidine analogues as novel inhibitors of Chikungunya virus","volume":"11","author":"Moesslacher","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.virs.2026.07.001_bib91","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02272-18","article-title":"Repurposing estrogen receptor antagonists for the treatment of infectious disease","volume":"9","author":"Montoya","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.virs.2026.07.001_bib92","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01943-21","article-title":"Selective estrogen receptor modulators limit alphavirus infection by targeting the viral capping enzyme nsP1","volume":"66","author":"Mudgal","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib93","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1873-3468.13642","article-title":"Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase","volume":"594","author":"Mudgal","year":"2019","journal-title":"FEBS Lett."},{"key":"10.1016\/j.virs.2026.07.001_bib94","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.micinf.2012.10.003","article-title":"Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle","volume":"15","author":"Murakami","year":"2013","journal-title":"Microb. Infect."},{"key":"10.1016\/j.virs.2026.07.001_bib95","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1021\/acs.jmedchem.5c00635","article-title":"Identification of direct-acting nsP2 helicase inhibitors with antialphaviral activity","volume":"68","author":"Muthu Ramalingam","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.focha.2025.101053","article-title":"Pharmaceutical perspectives of thymoquinone, a lead molecule from black cumin (Nigella sativa L.) with diverse biological targets","volume":"8","author":"Nainawat","year":"2025","journal-title":"Food Chem. Adv"},{"key":"10.1016\/j.virs.2026.07.001_bib97","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00135-21","article-title":"Radicicol inhibits Chikungunya virus replication by targeting nonstructural protein-2","volume":"65","author":"Nam","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib98","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijbiomac.2018.05.007","article-title":"Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site","volume":"116","author":"Narwal","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virs.2026.07.001_bib99","article-title":"Identification of inhibitors of Chikungunya virus nsP2 ATPase","author":"Navarro","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.virs.2026.07.001_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.01.001","article-title":"Identification of Chikungunya virus nsP2 protease inhibitors using structure-base approaches","volume":"57","author":"Nguyen","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.virs.2026.07.001_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscia.2025.100084","article-title":"Phenol and chromone compounds for in silico inhibition of nsP2 and nsP3 of Chikungunya virus","volume":"3","author":"Oliveira Lima","year":"2025","journal-title":"Pharm. Sci. Adv."},{"key":"10.1016\/j.virs.2026.07.001_bib102","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1111\/febs.16397","article-title":"Alphavirus antivirals targeting RNA-dependent RNA polymerase domain of nsP4 divulged using surface plasmon resonance","volume":"289","author":"Pareek","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.virs.2026.07.001_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ph13070141","article-title":"Computer-aided design, synthesis, and antiviral evaluation of novel acrylamides as potential inhibitors of E3-E2-E1 glycoproteins complex from Chikungunya virus","volume":"13","author":"Passos","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.virs.2026.07.001_bib104","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1473-3099(07)70107-X","article-title":"Chikungunya, an epidemic arbovirosis","volume":"7","author":"Pialoux","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib105","article-title":"Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays","volume":"6","author":"Pohjala","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.07.001_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117227","article-title":"Novel \u03b1-mangostin derivatives as promising antiviral agents: isolation, synthesis, and evaluation against chikungunya virus","volume":"284","author":"Priya","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib107","doi-asserted-by":"crossref","first-page":"20335","DOI":"10.1021\/acsomega.9b02900","article-title":"Evaluation of the antiviral potential of halogenated dihydrorugosaflavonoids and molecular modeling with nsP3 protein of Chikungunya virus (CHIKV)","volume":"4","author":"Puranik","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.virs.2026.07.001_bib108","doi-asserted-by":"crossref","first-page":"27632","DOI":"10.1021\/acsomega.4c03417","article-title":"In silico drug repurposing uncovered the antiviral potential of the antiparasitic drug oxibendazole against the Chikungunya virus","volume":"9","author":"Rabelo","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.virs.2026.07.001_bib109","article-title":"Antiviral activity of silymarin against Chikungunya virus","volume":"5","author":"Rafidah","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jmgm.2013.07.001","article-title":"Structure based design towards the identification of novel binding sites and inhibitors for the Chikungunya virus envelope proteins","volume":"44","author":"Rashad","year":"2013","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.virs.2026.07.001_bib111","article-title":"Withaferin A inhibits Chikungunya virus nsP2 protease and shows antiviral activity in the cell culture and mouse model of virus infection","volume":"20","author":"Rathore","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2026.07.001_bib112","article-title":"In-depth characterization of the Chikungunya virus replication cycle","volume":"96","author":"Reis","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib113","doi-asserted-by":"crossref","DOI":"10.1007\/s00894-021-04868-0","article-title":"Chikungunya nsP4 homology modeling reveals a common motif with Zika and Dengue RNA polymerases as a potential therapeutic target","volume":"27","author":"Reyes-Gastellou","year":"2021","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.virs.2026.07.001_bib114","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"Infection with Chikungunya virus in Italy: an outbreak in a temperate region","volume":"370","author":"Rezza","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.07.001_bib115","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1021\/acsmedchemlett.5c00515","article-title":"Restructuring antiviral quinazolinone frameworks to derive and optimize inhibitors of Chikungunya virus","volume":"16","author":"Roach","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.virs.2026.07.001_bib116","article-title":"A sensitive and robust high-throughput screening assay for inhibitors of the Chikungunya virus nsP1 capping enzyme","volume":"11","author":"Roques","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.07.001_bib117","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.str.2006.07.010","article-title":"The crystal structure of the Venezuelan equine encephalitis alphavirus nsP2 protease","volume":"14","author":"Russo","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.virs.2026.07.001_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/v15112194","article-title":"Identification of 2,4-diaminoquinazoline derivative as a potential small-molecule inhibitor against Chikungunya and Ross River viruses","volume":"15","author":"Saha","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2026.07.001_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-29024-2","article-title":"Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus","volume":"8","author":"Saha","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib120","article-title":"Chikungunya virus capsid protein contains nuclear import and export signals","volume":"10","author":"Saijo","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.virs.2026.07.001_bib121","article-title":"MBZM-N-IBT, a novel small molecule, restricts Chikungunya virus infection by targeting nsP2 protease activity in vitro, in vivo, and ex vivo","volume":"66","author":"Saikat","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.07.001_bib122","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcv.2009.07.016","article-title":"Chikungunya virus of Asian and Central\/East African genotypes in Malaysia","volume":"46","author":"Sam","year":"2009","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib123","article-title":"The effect of amantadine on an ion channel protein from Chikungunya virus","volume":"13","author":"Samy","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib124","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7705\/biomedica.4350","article-title":"S\u00edntomas subagudos y cr\u00f3nicos de la fiebre de chikungunya en un grupo de personas adultas en Ibagu\u00e9, Colombia","volume":"39","author":"S\u00e1nchez","year":"2019","journal-title":"Biomedica"},{"key":"10.1016\/j.virs.2026.07.001_bib125","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/acschembio.3c00046","article-title":"Palmitoylation-dependent small-molecule fluorescent probes for live-cell golgi imaging","volume":"18","author":"Sawada","year":"2023","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.virs.2026.07.001_bib126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.virs.2026.07.001_bib127","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmc.2016.10.037","article-title":"Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of Chikungunya virus replication","volume":"25","author":"Scuotto","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib128","article-title":"Novel computational pipeline to identify target sites for broad spectrum antiviral drugs","volume":"245","author":"Sears","year":"2025","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-81287-0","article-title":"The potential inhibitory mechanism of EGCG against the Chikungunya virus targeting non-structural protein 2 through molecular dynamics simulation","volume":"14","author":"Setyawati","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2026.07.001_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111956","article-title":"Identification of 6\u2032-\u03b2-fluoro-homoaristeromycin as a potent inhibitor of Chikungunya virus replication","volume":"187","author":"Shin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib131","article-title":"Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean","volume":"7","author":"Simon-Djamel","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib132","first-page":"243","article-title":"French guidelines for the management of Chikungunya (acute and persistent presentations)","volume":"45","author":"Simon","year":"2015","journal-title":"November 2014. M\u00e9d. Mal. Infect."},{"key":"10.1016\/j.virs.2026.07.001_bib133","first-page":"123","article-title":"Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands","volume":"86","author":"Simon","year":"2007","journal-title":"Report of 47 cases. Medicine"},{"key":"10.1016\/j.virs.2026.07.001_bib134","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2025.30.44.2500792","article-title":"Post-authorisation experience and reported adverse events following use of a virus-like particle Chikungunya vaccine, United States and Germany, up to August 2025","volume":"30","author":"Simone","year":"2025","journal-title":"Euro Surveill."},{"key":"10.1016\/j.virs.2026.07.001_bib135","article-title":"Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study","volume":"7","author":"Singh","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib136","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","article-title":"Replication cycle of Chikungunya: a re-emerging arbovirus","volume":"393","author":"Solignat","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.07.001_bib137","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115572","article-title":"Design, synthesis, antiviral evaluation, and in silico studies of acrylamides targeting nsP2 from Chikungunya virus","volume":"258","author":"Souza","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib138","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/0042-6822(92)90268-T","article-title":"Identification of the active site residues in the nsP2 proteinase of Sindbis virus","volume":"191","author":"Strauss","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.07.001_bib139","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/nar\/gkab1302","article-title":"Crystal structures of alphavirus nonstructural protein 4 (nsP4) reveal an intrinsically dynamic RNA-dependent RNA polymerase fold","volume":"50","author":"Tan","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virs.2026.07.001_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.144093","article-title":"New spirooxindole-benzothiazole hybrids incorporating a trifluoromethyl moiety as antiviral agents: design, synthesis, crystal structure analysis, and in silico studies","volume":"1351","author":"Temizer Keser","year":"2026","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.virs.2026.07.001_bib141","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02276-20","article-title":"Phosphorylation sites in the hypervariable domain in Chikungunya virus nsP3 are crucial for viral replication","volume":"95","author":"Teppor","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib142","doi-asserted-by":"crossref","first-page":"133","DOI":"10.56808\/2985-1130.2288","article-title":"Chikungunya virus in Thailand; an update","volume":"41","author":"Tiawsirisup","year":"2011","journal-title":"Thai J. Vet. Med."},{"key":"10.1016\/j.virs.2026.07.001_bib143","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(25)00372-1","article-title":"Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial","volume":"405","author":"Tindale","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.virs.2026.07.001_bib144","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00705-018-4079-0","article-title":"An estrogen antagonist, cyclofenil, has anti-dengue-virus activity","volume":"164","author":"Tohma","year":"2019","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib145","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2020.05.010","article-title":"Evaluation of novobiocin and telmisartan for anti-CHIKV activity","volume":"548","author":"Tripathi","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.07.001_bib146","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.coviro.2011.07.004","article-title":"Chikungunya virus: evolution and genetic determinants of emergence","volume":"1","author":"Tsetsarkin","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib147","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10822-022-00463-4","article-title":"In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus","volume":"36","author":"Verma","year":"2022","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.virs.2026.07.001_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106186","article-title":"Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo","volume":"239","author":"Verwimp","year":"2025","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib149","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2017.02.014","article-title":"Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus","volume":"505","author":"Wada","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.07.001_bib150","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijid.2017.03.006","article-title":"Global expansion of Chikungunya virus: mapping the 64-year history","volume":"58","author":"Wahid","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib151","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.1502135","article-title":"Experimental anti-inflammatory drug semapimod inhibits TLR signaling by targeting the TLR chaperone gp96","volume":"196","author":"Wang","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.virs.2026.07.001_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106591","article-title":"The Chikungunya virus outbreak in Foshan, China: a rising public health threat in tropical and subtropical regions","volume":"91","author":"Wang","year":"2025","journal-title":"J. Infect."},{"key":"10.1016\/j.virs.2026.07.001_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129949","article-title":"Drugs targeting structural and nonstructural proteins of the Chikungunya virus: a review","volume":"262","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virs.2026.07.001_bib154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.001","article-title":"The green tea catechin, epigallocatechin gallate inhibits Chikungunya virus infection","volume":"113","author":"Weber","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virs.2026.07.001_bib155","series-title":"Chikungunya Epidemiology Update - June 2025","year":"2025"},{"key":"10.1016\/j.virs.2026.07.001_bib156","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/jm00109a001","article-title":"S-adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy","volume":"34","author":"Wolfe","year":"1991","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib157","doi-asserted-by":"crossref","first-page":"26452","DOI":"10.1074\/jbc.M801470200","article-title":"The dynamic envelope of a fusion class II virus","volume":"283","author":"Wu","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib158","doi-asserted-by":"crossref","first-page":"S441","DOI":"10.1093\/infdis\/jiw390","article-title":"Epidemiology of Chikungunya in the americas","volume":"214","author":"Yactayo","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib159","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3201\/eid1210.060529","article-title":"Chikungunya outbreaks caused by African genotype, India","volume":"12","author":"Yergolkar","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virs.2026.07.001_bib160","article-title":"Chikungunya virus non-structural protein 1 is a versatile RNA capping and decapping enzyme","volume":"299","author":"Yien","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib161","article-title":"Identification and characterization of novel Chikungunya virus polymerase inhibitors","volume":"100","author":"Yin","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.07.001_bib162","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1021\/acs.jmedchem.9b00781","article-title":"Design, synthesis, and anti-RNA virus activity of 6\u2032-fluorinated-aristeromycin analogues","volume":"62","author":"Yoon","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.virs.2026.07.001_bib163","article-title":"Identification of 5-Iodotubercidin as a genotoxic drug with anti-cancer potential","volume":"8","author":"Zhang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.07.001_bib164","article-title":"Pyrimidone inhibitors targeting Chikungunya virus nsP3 macrodomain by fragment-based drug design","volume":"16","author":"Zhang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2026.07.001_bib165","article-title":"Investigation of a clinical trial drug VV261 as a potent antiviral candidate against Chikungunya virus","volume":"11","author":"Zhang","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virs.2026.07.001_bib166","doi-asserted-by":"crossref","DOI":"10.3390\/v18010100","article-title":"Chikungunya in 2025: comprehensive insights into virology, diagnostics, vaccines, and antiviral therapies","volume":"18","author":"Zheng","year":"2026","journal-title":"Viruses"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26001033?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26001033?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:36:17Z","timestamp":1789054577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26001033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":164,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1995820X26001033"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.07.001","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent progress in anti-Chikungunya virus drug discovery: Focus on the viral life cycle and direct-acting antivirals","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}